Assessing Quality of Care for the Myelodysplastic Syndromes.

about

P2860

Q51735716-CE065A5C-D7EA-46DE-A96C-3E610F81D814

P2860

Assessing Quality of Care for the Myelodysplastic Syndromes.

Item

http://www.wikidata.org/entity/Q38937504

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Assessing Quality of Care for the Myelodysplastic Syndromes.

@en

type

Item

label

Assessing Quality of Care for the Myelodysplastic Syndromes.

@en

prefLabel

Assessing Quality of Care for the Myelodysplastic Syndromes.

@en

P1476

Assessing Quality of Care for the Myelodysplastic Syndromes.

@en

P2093

Gregory A Abel

http://www.w3.org/2001/XMLSchema#string

Zachary A K Frosch

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

The effect of financial incentives on the quality of health care provided by primary care physicians

Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.

Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial.

Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota.

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer

Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines.

Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Measuring quality in oncology: challenges and opportunities.

P2888

s11899-016-0343-0

P304

402-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-016-0343-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000747881

http://www.w3.org/2001/XMLSchema#string

P698

27562670

http://www.w3.org/2001/XMLSchema#string

P921

quality of care

Assessing Quality of Care for the Myelodysplastic Syndromes.

about

P2860

P2860

Assessing Quality of Care for the Myelodysplastic Syndromes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921